Manufacturer record
Mayford Pharma Near Railway crossing: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Mayford Pharma Near Railway crossing (Himachal Pradesh) were declared Not of Standard Quality between November 2025 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Mayford Pharma Near Railway crossing in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ferrous Ascorbate, Folic Acid & Zinc Tablets | MMT-11855Mfg 2024-12 · Exp 2026-05 | Assay of Elemental Iron does not comply as per STP and as per IP 2022 the label should state the strength in terms of Ferrous ascorbate equivalent to Elemental Iron, but Ferin-XT tablets label is not mentioned Ferrous Ascorbate equivalent to Elemental Iron. Hence sample deemed to be Misbranded as per Section 17 of D & C act 1940.Assay | DCL TelanganaState lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.